Potential Role of Caffeine in the Treatment of Parkinson’s Disease

  title={Potential Role of Caffeine in the Treatment of Parkinson’s Disease},
  author={Mohsin H K Roshan and A. Tambo and N. Pace},
  journal={The Open Neurology Journal},
  pages={42 - 58}
  • Mohsin H K Roshan, A. Tambo, N. Pace
  • Published 2016
  • Psychology, Medicine
  • The Open Neurology Journal
  • Parkinson’s disease [PD] is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting 1% of the population over the age of 55. The underlying neuropathology seen in PD is characterised by progressive loss of dopaminergic neurons in the substantia nigra pars compacta with the presence of Lewy bodies. The Lewy bodies are composed of aggregates of α-synuclein. The motor manifestations of PD include a resting tremor, bradykinesia, and muscle rigidity. Currently there is… CONTINUE READING
    12 Citations
    Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease
    • 11
    • Highly Influenced
    Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson’s Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1)
    • W. Lu, Jinhuang Lin, +4 authors Peineng Chen
    • Chemistry, Medicine
    • Medical science monitor : international medical journal of experimental and clinical research
    • 2020
    Managing interactions between cognitive enhancers and other psychotropics


    Calcium dysregulation in Parkinson's disease.
    • A. Schapira
    • Psychology, Medicine
    • Brain : a journal of neurology
    • 2013
    • 34
    • PDF
    Progression of motor symptoms in Parkinson’s disease
    • 91
    Glutathione—a review on its role and significance in Parkinson's disease
    • H. Martin, P. Teismann
    • Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 2009
    • 246
    • PDF
    Role of Oxidative Stress in Parkinson's Disease
    • O. Hwang
    • Medicine
    • Experimental neurobiology
    • 2013
    • 711
    • PDF
    The Promise of Neuroprotective Agents in Parkinson’s Disease
    • 82
    • PDF
    Olfactory dysfunction in Parkinson disease
    • R. Doty
    • Medicine
    • Nature Reviews Neurology
    • 2012
    • 405
    • PDF
    Adenosine A2A receptors in Parkinson’s disease treatment
    • 74
    • PDF
    Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.
    • 192
    • PDF
    Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.
    • 87
    • PDF